Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2019-08-22 | 2020-01-17 | 92215 |
| TEVA-TOLTERODINE | 1MG | TABLET | Resolved | 2019-08-22 | 2021-08-05 | 92218 |
| ACT LATANOPROST/TIMOLOL | 5MG 50MCG | SOLUTION | Resolved | 2019-08-22 | 2019-10-24 | 92229 |
| ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2019-08-22 | 2021-02-12 | 92232 |
| ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2019-08-22 | 2020-03-12 | 92235 |
| TEVA-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-08-22 | 2020-04-16 | 92238 |
| TEVA-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-08-22 | 2020-02-07 | 92241 |
| TEVA-TECNAL | 330MG 50MG 40MG | CAPSULE | Resolved | 2019-08-29 | 2020-07-10 | 92657 |
| APRI 28 | 0.15MG 0.03MG | TABLET | Resolved | 2019-08-29 | 2019-10-24 | 92660 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2019-08-29 | 2020-01-30 | 92663 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-08-29 | 2019-10-24 | 92666 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-08-29 | 2019-10-24 | 92669 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-08-29 | 2019-11-08 | 92672 |
| TEVA-NABILONE | 0.5MG | CAPSULE | Resolved | 2019-08-29 | 2019-11-21 | 92675 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2019-08-29 | 2019-10-26 | 92678 |
| RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2019-08-29 | 2019-10-26 | 92681 |
| ACT SUMATRIPTAN | 100MG | TABLET | Resolved | 2019-08-29 | 2020-07-10 | 92684 |
| AMPICILLIN SODIUM FOR INJECTION, USP | 250MG | POWDER FOR SOLUTION | Resolved | 2019-09-05 | 2019-09-19 | 93110 |
| TEVA-BUDESONIDE | 0.5MG | SUSPENSION | Resolved | 2019-09-05 | 2019-12-19 | 93131 |
| TEVA-MONTELUKAST | 5MG | TABLET (CHEWABLE) | Resolved | 2019-09-05 | 2019-09-27 | 93134 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | To be discontinued | 2019-07-05 | 2019-07-05 | 88619 |
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |